Astellas Settles Patent Suit Over Generic Adenoscan

Law360, Los Angeles (July 12, 2011, 5:49 PM EDT) -- Astellas Pharma US Inc. settled a lawsuit Monday in New Jersey that accused generics makers Sagent Pharmaceuticals Inc. and Strides Arcolab Ltd. of violating its patent covering pharmacologic stress agent Adenoscan.

It was not clear on Tuesday whether the settlement included a provision that would allow Sagent Strides LLC, a joint venture between the two defendant companies, to market and sell an Adenoscan generic under a license agreement — an arrangement Astellas has made with other generic-drug makers.

Terms of the deal were not immediately available...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.